Brunei Darussalam vs Brunei Darussalam: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Brunei Darussalam
0.7%
in 2024
Brunei Darussalam
0.7%
in 2024
Brunei Darussalam rank
51st
Brunei Darussalam rank
51st
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Brunei Darussalam
- Brunei Darussalam
How they compare
Brunei Darussalam currently reports 0.7% against 0.7% in Brunei Darussalam, a difference of 0.0%.
Across all 10 years both countries report, Brunei Darussalam has been ahead every year.
Brunei Darussalam ranks 51st and Brunei Darussalam ranks 51st of 246 countries.
Head to head by decade
| Decade | Brunei Darussalam | Brunei Darussalam | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.9% | 0.9% | 0.0% | — |
| 2020s | 0.8% | 0.8% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Brunei Darussalam or Brunei Darussalam?
- Brunei Darussalam, at 0.7% against 0.7% in Brunei Darussalam as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Brunei Darussalam and Brunei Darussalam?
- 0.0%, with Brunei Darussalam ahead.
- How many years of comparable data are there for Brunei Darussalam and Brunei Darussalam?
- 10 years are reported by both, from 2015 to 2024.
- How do Brunei Darussalam and Brunei Darussalam rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Brunei Darussalam ranks 51st and Brunei Darussalam ranks 51st of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.